Thoracic Lymphatic Pump Techniques for Reducing Lung Volumes in Persons With Chronic Obstructive Pulmonary Disease

NCT02030145 | Withdrawn

• 2 other identifiers: AOA Grant #06-04-54506-04-545
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The primary goal of this line of research is to see if realistic manipulative protocols can be developed to produce sustained reductions in residual volume and improve pulmonary function parameters in people with Chronic Obstructive Pulmonary Disease (COPD).

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD; Pulmonary

Outcome Measures

Primary Outcomes (1)

• Pulmonary function tests

  Tests will be conducted by body plethysmography utilizing the MedGraphics® 1085 Series™ to measure changes in pulmonary function.

  30 minutes and 3 hours post-treatment

Study Arms (2)

Classic Thoracic Lymphatic Pump

ACTIVE COMPARATOR

Subjects begin with Classic Thoracic Lymphatic Pump, then crossover to Compressive Thoracic Lymphatic Pump after 4-week washout period.

Procedure: Compressive Thoracic Lymphatic Pump; Procedure: Classic Thoracic Lymphatic Pump

Compressive Thoracic Lymphatic Pump

EXPERIMENTAL

Subjects begin with Compressive Thoracic Lymphatic Pump, then crossover to Classic Thoracic Lymphatic Pump after 4-week washout period.

Procedure: Compressive Thoracic Lymphatic Pump; Procedure: Classic Thoracic Lymphatic Pump

Interventions

Compressive Thoracic Lymphatic Pump PROCEDURE

This technique is a modification of the Classic Thoracic Lymphatic Pump where some pressure is maintained on the chest wall at the end of each exhalation and at the end of the third or fourth breathing cycle, during the inhalation phase, the hands are slowly removed from the chest wall, gradually releasing pressure on the chest without causing a sudden change in intrathoracic pressures.

Also known as: Modified TLP

Classic Thoracic Lymphatic Pump; Compressive Thoracic Lymphatic Pump

Classic Thoracic Lymphatic Pump PROCEDURE

This technique is well described in Chapter 68 of the Foundations for Osteopathic Medicine, 2nd Edition.

Also known as: TLP

Classic Thoracic Lymphatic Pump; Compressive Thoracic Lymphatic Pump

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

Sponsors & Collaborators

• A.T. Still University of Health Sciences: lead
• American Osteopathic Association: collaborator

Study Sites (1)

A.T. Still University of Health Sciences

Kirksville, Missouri, 63501, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Donald R. Noll, D.O.

  A.T. Still University of Health Sciences

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 22, 2011
• First Posted: January 8, 2014
• Study Start: February 1, 2007
• Primary Completion: February 1, 2008
• Study Completion: February 1, 2008
• Last Updated: January 8, 2014

Record last verified: 2011-07

Locations

US (1)